Cabozantinib S-malate T1797
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cabozantinib S-malate is the s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.
CAS nr:
1140909-48-3
Purity:
98%
Molecular Weight:
635,59
SMILES:
O[C@@H](CC(O)=O)C(O)=O.COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC
Formula:
C32H30FN3O10
Pathway:
Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Apoptosis,Tyrosine Kinase/Adaptors
Target:
c-Met/HGFR,VEGFR,VEGFR,TAM Receptor,Apoptosis,c-Kit
